Telescope Innovations Corp. (CSE:TELI)

Canada flag Canada · Delayed Price · Currency is CAD
0.350
-0.020 (-5.41%)
At close: Mar 3, 2026
6.06%
Market Cap 28.28M
Revenue (ttm) 6.28M
Net Income (ttm) -2.43M
Shares Out 80.81M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18,000
Average Volume 58,026
Open 0.375
Previous Close 0.370
Day's Range 0.350 - 0.375
52-Week Range 0.230 - 0.650
Beta 1.57
RSI 45.14
Earnings Date Apr 21, 2026

About Telescope Innovations

Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. It offers DIRECTINJECT-LCTM, a hardware and software ecosystem that enables direct sampling and analysis of chemical reactions. It also provides intellectual property and contract research services. It serves pharmaceutical, critical minerals, and chemical industries. Telescope Innovations Corp. has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. ... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Henry Dubina
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol TELI
Full Company Profile

Financial Performance

In fiscal year 2025, Telescope Innovations's revenue was 4.78 million, an increase of 12.03% compared to the previous year's 4.27 million. Losses were -1.56 million, 18.1% more than in 2024.

Financial Statements

News

There is no news available yet.